🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Epidermolysis Bullosa Simplex

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized NCT06509984Phase 24 sites📍 Nice📍 Paris📍 Paris Centre Hospitalier Universitaire de Nice · Tests: Apremilast treatment A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex NCT07027345Phase 22 sites📍 Palo Alto📍 Chicago BioMendics, LLC · Tests: 5% TolaSure Topical Gel, Topical Placebo Gel A Study to Evaluate ENERGI-F703EB Cream in Epidermolysis Bullosa NCT07858422Phase 21 site📍 Tainan Energenesis Biomedical Co., Ltd. · Tests: ENERGI-F703EB Cream, Matched vehicle cream
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy